Top

Published in:

01-02-2013 | Original Article

Increased risk of hepatitis E virus infection in schizophrenia

Authors: Yong Xue, Xiaohua Sun, Yinghui Li, Xin Liu, Chen Dong

Published in: Archives of Virology | Issue 2/2013

Abstract

Until now, the risk of HEV infection in schizophrenia was unknown. The present results showed that the seroprevalence of anti-HEV IgG and anti-HEV IgM in schizophrenia were significantly higher than that in healthy controls. Anti-HEV IgG positivity increased with age and with the duration of disease in schizophrenia patients. Moreover, schizophrenia patients with increased CD4⁺/CD8⁺ T-cell ratios (>2.03) had higher anti-HEV IgG detection rates than those with normal ratios (1.05-2.03). Compared with the schizophrenia patients who tested anti-HEV IgG negative, the levels of interleukin-4 and interleukin-10 (Th2 cytokines) were significantly higher, while the interleukin-12 (Th1 cytokine) level was significantly lower, in those with anti-HEV IgG positivity. Of five schizophrenia patients who were anti-HEV IgM positive, four had elevated CD4⁺/CD8⁺ T-cell ratios. HEV RNA was isolated from one of these four patients and classified as genotype 4. Anti-HEV IgM positivity was not detected among healthy controls. Therefore, schizophrenia patients exhibited a higher risk of HEV infection than controls.

Aggarwal R, Naik S (2009) Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 24:1484–1493PubMedCrossRef

Corwin AL, Tien NT, Bounlu K, Winarno J, Putri MP, Laras K et al (1999) The unique riverine ecology of hepatitis E virus transmission in South-East Asia. Trans R Soc Trop Med Hyg 93:255–260PubMedCrossRef

Dickerson F, Stallings C, Origoni A, Copp C, Khushalani S, Yolken Rc (2010) Antibodies to measles in individuals with recent onset psychosis. Schizophr Res 119:89–94PubMedCrossRef

Dong C, Dai X, Shao JS, Hu K, Meng JH (2007) Identification of genetic diversity of hepatitis E virus (HEV) and determination of the seroprevalence of HEV in eastern China. Arch Virol 152:739–746PubMedCrossRef

Dong C, Dai X, Meng JH (2007) The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E. Vaccine 25:1662–1668PubMedCrossRef

Dong C, Meng J, Dai X, Liang JH, Feagins AR, Meng XJ et al (2011) Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol 49:4164–4172PubMedCrossRef

Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J et al (2012) Suppression of interferon-α signaling by hepatitis E virus. Hepatology 55:1324–1332PubMedCrossRef

Dyer JG, McGuinness TM (2008) Reducing HIV risk among people with serious mental illness. J Psychosoc Nurs Ment Health Serv 46:26–34PubMed

Emerson SU, Anderson D, Arankalle VA, Meng XJ, Purdy M, Schlauder GG et al (2004) Hepevirus. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (eds) Virus Taxonomy, VIIIth Report of the ICTV. Elsevier/Acadmic Press, London, pp 851–855

10.

Essock SM, Dowden S, Constantine NT, Katz L, Swartz MS, Meador KG et al (2003) Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatr Serv 54:836–841PubMedCrossRef

11.

Fourquet E, Mansuy JM, Bureau C, Recher C, Vinel JP, Izopet J et al (2010) Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 49:141–144CrossRef

12.

Hazam RK, Singla R, Kishore J, Singh S, Gupta RK, Kar P (2010) Surveillance of hepatitis E virus in sewage and drinking water in a resettlement colony of Delhi: what has been the experience? Arch Virol 155:1227–1233PubMedCrossRef

13.

Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Kilbourne A, Goldberg R et al (2009) Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis. Psychosomatics 50:30–37PubMedCrossRef

14.

Husain MM, Aggarwal R, Kumar D, Jameel S, Naik S (2011) Effector T cells immune reactivity among patients with acute hepatitis E. J Viral Hepat 18:e603–e608PubMedCrossRef

15.

Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D et al (2012) Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 93:617–623PubMed

16.

Kamili S (2011) Toward the development of a hepatitis E vaccine. Virus Res 16:93–100CrossRef

17.

Kc S, Sharma D, Basnet BK, Mishra AK (2009) Effect of acute hepatitis E infection in patients with liver cirrhosis. JNMA J Nepal Med Assoc 48:226–229PubMed

18.

Kelly JA, Murphy DA, Sikkema KJ, Somlai AM, Mulry GW, Fernandez MI et al (1995) Predictors of high and low levels of HIV risk behavior among adults with chronic mental illness. Psychiatr Serv 46:813–818PubMed

19.

Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI (1981) Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252–255PubMedCrossRef

20.

Nagai H, Miyaki D, Matsui T, Kanayama M, Higami K, Momiyama K (2008) Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemother Pharmacol 62:959–963PubMedCrossRef

21.

Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB et al (2011) Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J Affect Disord 130:220–225PubMedCrossRef

22.

Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S (2005) Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 20:1094–1101PubMedCrossRef

23.

Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808PubMedCrossRef

24.

Purcell RH, Emerson SU (2008) Hepatitis E: an emerging awareness of old disease. J Hepatol 48:494–503PubMedCrossRef

25.

Rector NA, Seeman MV (1992) Schizophrenia and AIDS. Hospital and Community Psychiatry 43:181–182PubMed

26.

Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI et al (2001) Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 91:31–37PubMedCrossRef

27.

Sato Y, Sato H, Naka K, Furuya S, Tsukiji H, Kitagawa K et al (2011) A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes. Arch Virol 156:1345–1358PubMedCrossRef

28.

Severance EG, Dickerson FB, Viscidi RP, Bossis I, Stallings CR, Origoni AE et al (2011) Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull 37:101–107PubMedCrossRef

29.

Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL (2008) Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res 106:268–274PubMedCrossRef

30.

Suvisaari J, Loo BM, Saarni SE, Haukka J, Perälä J, Saarni SI et al (2011) Inflammation in psychotic disorders: a population-based study. Psychiatry Res 189:305–311PubMedCrossRef

31.

Tappe D, Müller A, Ziegler U, Weissbrich B, Schubert J, Günther S et al (2010) Positive hepatitis E and Epstein Barr virus serology in a patient with jaundice after travel. J Clin Virol 48:78–81PubMedCrossRef

32.

Teo CG (2007) The two clinico-epidemiological forms of hepatitis E. J Viral Hepat 14:295–297PubMedCrossRef

33.

Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S et al (2010) Hepatitis E epidemic, Uganda. Emerg Infect Dis 16:126–129PubMedCrossRef

34.

Tripathy AS, Das R, Rathod SB, Arankalle VA (2012) Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection. PLoS One 7:e31822PubMedCrossRef

35.

Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ et al (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376:895–902PubMedCrossRef

Title: Increased risk of hepatitis E virus infection in schizophrenia
Authors: Yong Xue
Xiaohua Sun
Yinghui Li
Xin Liu
Chen Dong
Publication date: 01-02-2013
Publisher: Springer Vienna
Published in: Archives of Virology / Issue 2/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-012-1494-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Increased risk of hepatitis E virus infection in schizophrenia

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Characterization and distribution of tomato yellow margin leaf curl virus, a begomovirus from Venezuela

The complete genome sequence of a Brazilian isolate of yam mild mosaic virus

Development of a full-length infectious clone of sunflower chlorotic mottle virus (SuCMoV)

Characterization of low-pathogenic H6N6 avian influenza viruses in central China

Pathway analysis in blood cells of pigs infected with classical swine fever virus: comparison of pigs that develop a chronic form of infection or recover

Soybean chlorotic spot virus, a novel begomovirus infecting soybean in Brazil

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page